Tip: Try author name, DOI (10.xxxx/…), or keywords.

ISSN (Online): 1694-4674
🔧 Filters
Search Annals of Medicine and Medical Sciences
Try: author name · keyword phrase · DOI
11 results for "Chemotherapy"
Bagmi Mishra, Pushpanjali Behera, Anup Kumar Pramanik, Subrat Kumar Samantara +2 more
Background: Background: High-grade salivary gland carcinomas (SGCs) often lack architectural hallmarks, leading to their classification as "Adenocarcinoma, Not Otherwise Specified" (ANOS). This "waste
Salivary Duct Carcinoma AdenocarcinomaNOS Androgen Receptor Precision Oncology Immunohistochemistry India
🗓 Apr 2026pp. 528 - 533View Article →
Pragnya Swastika Pujahari, Sukanta Kumar Dash, Bablu Tudu, Jyotiranjan Mohapatra +1 more
Background: The perioperative period is a "vulnerable window" where surgical stress and anesthetic choice may influence long-term oncological prognosis. This review evaluates the impact of anesthetic
Breast cancer surgeryAnesthetic modalitiesOncological outcomesImmune modulation
🗓 Apr 2026pp. 477 - 486View Article →
Anila Sharma, Raja Langer, Ankur Kumar, Gurudutt Gupta
The breast is a rare location for the development of a malignant lymphoma with the incidence of Primary breast lymphoma (PBL) being less than 0.5% of all breast malignancies and 2% of all extranodal l
Breast LymphomaExtranodalDLBCLImmunohistochemistryChemotherapy
🗓 Apr 2026pp. 463 - 467View Article →
Nevy Shinta Damayanti, Noni Novisari Soeroso, Setia Putra Tarigan, Desfrina Kasuma +2 more
Background: Lung cancer remains the leading cause of cancer-related mortality worldwide, with most cases diagnosed at advanced stages. In non–small cell lung cancer (NSCLC), inflammation plays a criti
nonsmall cell lung cancer interferon-gamma AHCC chemotherapy quality of life
🗓 Apr 2026pp. 437 - 443View Article →
Zamindar Zamindar, Noni Novisari Soeroso, Setia Putra Tarigan, Elisna Syahruddin +2 more
Background: Transforming growth factor-beta (TGF-β) is a key immunosuppressive cytokine involved in tumor progression, immune evasion, and therapeutic resistance in non–small cell lung cancer (NSCLC).
Nonsmall cell lung cancer AHCC Transforming growth factor-beta TGF- Immunomodulation Platinum-based chemotherapy
🗓 Apr 2026pp. 367 - 371View Article →
Objective: To evaluate the efficacy, safety, and clinical impact of blinatumomab across the treatment continuum of B-cell acute lymphoblastic leukemia. Design: Systematic evidence synthesis of randomi
Acute Lymphoblastic LeukemiaBlinatumomabImmunotherapyMinimal Residual DiseaseSurvival Analysis
🗓 Mar 2026pp. 267 - 272View Article →
Objective: To describe an exceptionally rare occurrence of chronic myeloid leukemia developing in the setting of relapsed refractory classical Hodgkin lymphoma following multi line chemotherapy, and t
ChemotherapyCombinationHodgkin DiseaseLeukemiaMyelogenousChronic
🗓 Feb 2026pp. 125 - 131View Article →
Background: Capecitabine–oxaliplatin (CAPOX) is a commonly used chemotherapy regimen in gastric and colorectal malignancies. Although its efficacy has been well established in randomized trials, real-
CAPOXgastric cancerrectal cancerchemotherapy toxicitytreatment compliance
🗓 Jan 2026pp. 17 - 21View Article →
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting toxicity of neurotoxic chemotherapy that significantly impairs quality of life (QoL) and functional status. Des
Chemotherapy-induced peripheral neuropathyCIPNtaxanesoxaliplatinbortezomibquality of life
🗓 Dec 2025pp. 1635 - 1639View Article →
Background: Anemia is a frequent comorbidity in women with gynecological malignancies, adversely affecting tolerance to surgery, chemotherapy, and radiotherapy. Despite its clinical relevance, Indian
anemiagynecologic cancercervix carcinomaovarian cancerprevalence
🗓 Nov 2025pp. 1462 - 1467View Article →
Objective: Cancer and chemotherapy are known risk factors for venous thromboembolism (VTE), and 75% of VTE-related deaths among cancer patients have been shown to occur in-hospital and 14% due to conf
Cancer-associated thrombosisKnowledgeOncologistsPracticeSudanThromboprophylaxis
🗓 Aug 2025pp. 779 - 785View Article →